# Qulipta

NDC: 0074-7096
Generic name: Atogepant
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210930

FDA application: NDA215206

## Active ingredients

- ATOGEPANT: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-7096"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-7096
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c8ab8f4-32bd-497a-befa-70c8a51d8d52